[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate
C33H31ClF5N7O3 — CID 138551821
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate
[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate (PubChem CID 138551821) has the molecular formula C33H31ClF5N7O3 and a molecular weight of 704.10 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate.
Molecular Properties
| Compound Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate |
|---|---|
| PubChem CID | 138551821 |
| Molecular Formula | C33H31ClF5N7O3 |
| Molecular Weight | 704.10 g/mol |
| Exact Mass | 703.21 |
| IUPAC Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-[(E)-3,3-dimethylbut-1-enyl]-5-oxoimidazol-1-yl]-2-(4-chloro-3-cyanophenyl)ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate |
| SMILES | CC(C)(C)/C=C/[C@]1(c2ccc(-c3cnn(C(F)F)c3)cc2)N=C(N)N([C@H](COC(=O)NC2(C(F)(F)F)CC2)c2ccc(Cl)c(C#N)c2)C1=O |
| InChI | InChI=1S/C33H31ClF5N7O3/c1-30(2,3)10-13-32(23-7-4-19(5-8-23)22-16-42-45(17-22)27(35)36)26(47)46(28(41)43-32)25(20-6-9-24(34)21(14-20)15-40)18-49-29(48)44-31(11-12-31)33(37,38)39/h4-10,13-14,16-17,25,27H,11-12,18H2,1-3H3,(H2,41,43)(H,44,48)/b13-10+/t25-,32-/m1/s1 |
| InChIKey | HTNVNYIBUYEVER-OSQDQKPZSA-N |
| XLogP | 6.99 |
| TPSA | 138.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 704.10 |
| LogP ≤ 5 | 6.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138551821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.